-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Avalo Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2016 to Q2 2024.
- Avalo Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 7.65M shares, a 13046% increase year-over-year.
- Avalo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 278K shares, a 608% increase from 2022.
- Avalo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 39.2K shares.
- Avalo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2018 was 34.8M shares, a 85.4% increase from 2017.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)